AI assistant
Chemomab Therapeutics Ltd. — Director's Dealing 2021
Apr 21, 2021
35107_dirs_2021-04-21_7bda1c75-d2fb-45d6-b0e6-65e5af1f3014.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-04-19
Reporting Person: Darvish Nissim (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-19 | Option to Purchase American Depositary Shares | $27.26 | A | 11884 | Acquired | 2031-04-19 | American Depositary Shares (11884) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to Purchase American Depositary Shares | $0.8 | 2026-10-27 | American Depositary Shares (10123) | 10123 | Direct |
Footnotes
F1: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
F2: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F3: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4: The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.